KIAA1841 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.015600E-01
Normal-vs-Stage2
4.464800E-01
Normal-vs-Stage3
7.504200E-01
Normal-vs-Stage4
3.752800E-01
Stage1-vs-Stage2
4.801200E-01
Stage1-vs-Stage3
5.106400E-01
Stage1-vs-Stage4
4.066000E-01
Stage2-vs-Stage3
1.654350E-01
Stage2-vs-Stage4
7.679800E-01
Stage3-vs-Stage4
2.510200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.468400E-01
Normal-vs-AfricanAmerican
7.359600E-01
Normal-vs-Asian
3.519200E-01
Caucasian-vs-AfricanAmerican
6.584600E-01
Caucasian-vs-Asian
9.064400E-01
AfricanAmerican-vs-Asian
6.287800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.335800E-01
Normal-vs-Female
4.764000E-01
Male-vs-Female
5.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.116800E-01
Normal-vs-Age(41-60Yrs)
2.162000E-01
Normal-vs-Age(61-80Yrs)
5.855200E-01
Normal-vs-Age(81-100Yrs)
6.066000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.529400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.078200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.986000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.904350E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.542600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.224800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.992800E-01
Normal-vs-Daily Drinker
4.658600E-01
Normal-vs-Weekly Drinker
5.220400E-01
Normal-vs-Occasional Drinker
1.243760E-01
Normal-vs-Social Drinker
5.259200E-01
Non Drinker-vs-Daily Drinker
8.980400E-01
Non Drinker-vs-Weekly Drinker
9.844600E-01
Non Drinker-vs-Occasional Drinker
2.138600E-01
Non Drinker-vs-Social Drinker
7.115400E-01
Daily Drinker-vs-Weekly Drinker
9.312200E-01
Daily Drinker-vs-Occasional Drinker
2.820600E-01
Daily Drinker-vs-Social Drinker
6.316200E-01
Weekly Drinker-vs-Occasional Drinker
2.874200E-01
Weekly Drinker-vs-Social Drinker
7.282000E-01
Occasional Drinker-vs-Social Drinker
8.778200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.716580E-01
Normal-vs-Grade 2
3.381600E-02
Normal-vs-Grade 3
2.159700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.879810E-02
Grade 1-vs-Grade 3
3.130400E-02
Grade 1-vs-Grade 4
1.716580E-01
Grade 2-vs-Grade 3
9.013400E-01
Grade 2-vs-Grade 4
3.381600E-02
Grade 3-vs-Grade 4
2.159700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.505400E-01
Normal-vs-NonDiabetic
3.447600E-01
Diabetic-vs-NonDiabetic
5.079500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.489240E-01
Normal-vs-NoPancreatitis
4.971800E-01
Pancreatitis-vs-NoPancreatitis
2.277600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.491800E-01
Normal-vs-N1
4.528400E-01
N0-vs-N1
9.142000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.737400E-01
Normal-vs-TP53-NonMutant
7.907000E-01
TP53-Mutant-vs-TP53-NonMutant
1.550110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
